Synonyms: AMG 102 | AMG102
Compound class:
Antibody
Comment: Rilotumumab is a monoclonal antibody directed against hepatocyte growth factor (HGF), developed as a treatment for solid tumours.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Peptide sequence BLAST search using the heavy and light chain variable regions of rilotumumab provides 100% matches to sequences covered by patent US8609090 [1], and to the antibody with designation 2.12.1. |
Classification | |
Compound class | Antibody |
International Nonproprietary Names | |
INN number | INN |
9123 | rilotumumab |
Synonyms |
AMG 102 | AMG102 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 302 |
Other databases | |
GtoPdb PubChem SID | 249565667 |
Search PubMed clinical trials | rilotumumab |
Search PubMed titles | rilotumumab |
Search PubMed titles/abstracts | rilotumumab |
Wikipedia | Rilotumumab |